| 592 ATR-mediated CD47 and PD-L1 upregulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer RCE Hsieh, S Krishnan, RC Wu, A Boda, A Liu, M Winkler, WH Hsu, S Lin, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 3 | 2021 |
| Abstract IA014: Synthetic essentiality identifies TDO2 as a key target in APC-deficient CRC R Lee, J Li, J Li, CJ Wu, S Jiang, WH Hsu, D Chakravarti, P Chen, ... Cancer Research 82 (23_Supplement_1), IA014-IA014, 2022 | | 2022 |
| ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer RCE Hsieh, S Krishnan, RC Wu, AR Boda, A Liu, M Winkler, WH Hsu, ... Science immunology 7 (72), eabl9330, 2022 | 78 | 2022 |
| ATR-MEDIATED CD47 AND PD-L1 UPREGULATION RESTRICTS RADIOTHERAPY-INDUCED IMMUNE PRIMING AND ABSCOPAL RESPONSES IN COLORECTAL CANCER RCE Hsieh, S Krishnan, RC Wu, A Boda, A Liu, M Winkler, WH Hsu, S Lin, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 9, A622-A622, 2021 | | 2021 |
| Cancer stemness meets immunity: from mechanism to therapy P Chen, WH Hsu, J Han, Y Xia, RA DePinho Cell reports 34 (1), 2021 | 162 | 2021 |
| Circadian regulator CLOCK drives immunosuppression in glioblastoma W Xuan, WH Hsu, F Khan, M Dunterman, L Pang, DA Wainwright, ... Cancer immunology research 10 (6), 770-784, 2022 | 50 | 2022 |
| Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma L Pang, M Dunterman, W Xuan, A Gonzalez, Y Lin, WH Hsu, F Khan, ... Cell reports 42 (2), 2023 | 31 | 2023 |
| Circadian regulator CLOCK recruits immune-suppressive microglia into the GBM tumor microenvironment P Chen, WH Hsu, A Chang, Z Tan, Z Lan, A Zhou, DJ Spring, FF Lang, ... Cancer discovery 10 (3), 371-381, 2020 | 140 | 2020 |
| Circadian regulator CLOCK recruits immune-suppressive microglia into the GBM tumor microenvironment. Cancer Discov. 2020; 10 (3): 371–81 P Chen, WH Hsu, A Chang, Z Tan, Z Lan, A Zhou, DJ Spring, FF Lang, ... CD-19-0400.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 4 | |
| Connective tissue growth factor activates pluripotency genes and mesenchymal–epithelial transition in head and neck cancer cells CC Chang, WH Hsu, CC Wang, CH Chou, MYP Kuo, BR Lin, ST Chen, ... Cancer research 73 (13), 4147-4157, 2013 | 98 | 2013 |
| GCN2 is a determinant of the response to WEE1 kinase inhibition in small-cell lung cancer AP Drainas, WH Hsu, AE Dallas, CD Poltorack, JW Kim, A He, GL Coles, ... Cell Reports 43 (8), 2024 | | 2024 |
| Histone demethylase KDM5D drives sex-specific differences in colorectal cancer J Li, Z Lan, W Liao, J Liu, S Jiang, HS Shim, M Slotnik, KA LaBella, ... Cancer Research 83 (7_Supplement), 3515-3515, 2023 | | 2023 |
| Histone demethylase KDM5D upregulation drives sex differences in colon cancer J Li, Z Lan, W Liao, JW Horner, X Xu, J Liu, Y Yoshihama, S Jiang, ... Nature 619 (7970), 632-639, 2023 | 44 | 2023 |
| Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation WH Yang, YH Su, WH Hsu, CC Wang, JL Arbiser, MH Yang Oncogene 35 (18), 2287-2298, 2016 | 52 | 2016 |
| Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma L Pang, M Dunterman, S Guo, F Khan, Y Liu, E Taefi, A Bahrami, C Geula, ... Nature Immunology 24 (10), 1654-1670, 2023 | 12 | 2023 |
| Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression F Khan, Y Lin, H Ali, L Pang, M Dunterman, WH Hsu, K Frenis, ... Nature communications 15 (1), 1987, 2024 | 4 | 2024 |
| LDHA-regulated tumor-macrophage symbiosis promotes glioblastoma progression F Khan, Y Lin, H Ali, L Pang, M Dunterman, WH Hsu, K Frenis, RG Rowe, ... Research Square, 2023 | 4 | 2023 |
| let-7 modulates chromatin configuration and target gene repression through regulation of the ARID3B complex TT Liao, WH Hsu, CH Ho, WL Hwang, HY Lan, T Lo, CC Chang, SK Tai, ... Cell reports 14 (3), 520-533, 2016 | 52 | 2016 |
| Lymphotoxin-β interacts with methylated EGFR to mediate acquired resistance to cetuximab in head and neck cancer DSS Hsu, WL Hwang, CH Yuh, CH Chu, YH Ho, PB Chen, HS Lin, HK Lin, ... Clinical Cancer Research 23 (15), 4388-4401, 2017 | 31 | 2017 |
| MYELOID-DIRECTED TREATMENT USING THE TLR7/8 AGONIST RESIQUIMOD IMPROVES THE SURVIVAL OF MICE WITH MEDULLOBLASTOMA AND ENHANCES EFFICACY OF RADIOTHERAPY. W Xuan, WH Hsu, F Khan, M Dunterman, L Pang, D Wainwright, A Ahmed, ... NEURO-ONCOLOGY 24, 289-289, 2022 | | 2022 |
